| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 18 Mar 24 | RVNC Revance Therapeutics | Common Stock | Sell | Dispose S | No | No | 5.0426 | 8,125 | 40.97 k | 137,815 |
| 15 Mar 24 | RVNC Revance Therapeutics | Common Stock | Payment of exercise | Dispose F | No | No | 5.305 | 3,269 | 17.34 k | 145,940 |
| 29 Feb 24 | RVNC Revance Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 15,143 | 0.00 | 149,209 |
| 31 Jan 24 | RVNC Revance Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 90,000 | 0.00 | 134,066 |
| 31 Jan 24 | RVNC Revance Therapeutics | Performance Stock Units Common Stock | Grant | Acquire A | No | No | 0 | 135,000 | 0.00 | 135,000 |
| 6 Sep 23 | RVNC Revance Therapeutics | Common Stock | Sell | Dispose S | No | Yes | 17.064 | 11,000 | 187.70 k | 44,066 |
| 5 Sep 23 | RVNC Revance Therapeutics | Common Stock | Sell | Dispose S | No | Yes | 17.8141 | 23,853 | 424.92 k | 55,066 |
| 11 Aug 23 | RVNC Revance Therapeutics | Common Stock | Payment of exercise | Dispose F | No | No | 18.91 | 9,592 | 181.38 k | 78,919 |
| 11 Aug 23 | RVNC Revance Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 19,346 | 0.00 | 88,511 |
